Quantcast

Latest cell therapy Stories

2014-09-17 16:25:43

LONDON, Sept. 17, 2014 /PRNewswire/ -- U.S. National Institute of Health stated that regenerative medicine is the process of creating functional tissue to repair and replace tissue or organ which has lost their function due to damage, congenital defects, disease and age. Moreover, it has included stem cell therapy, tissue engineering and biomaterial under the umbrella of regenerative medicine. Regenerative medicine has wide areas of application such as cardiovascular, neurology,...

2014-09-16 08:32:06

WELLESLEY, Massachusetts, September 16, 2014 /PRNewswire/ -- BCC Research reveals in its new report, THE GLOBAL MARKET FOR STEM CELLS [http://www.bccresearch.com/market-research/biotechnology/stem-cells-bio035e.html ], the global market for stem cells is expected to grow to nearly $10.6 billion by 2018, with a five-year compound annual growth rate (CAGR) of 13.6%. The highest growth will be witnessed in the Americas with growth projections of $2.2 billion in 2014 to $3.9...

2014-09-15 23:09:12

ChinaMarketResearchReports.com adds Latest Report on “Global and China Stem Cell Industry Report, 2014-2017” to its store. Inquire before buying on this report at http://www.chinamarketresearchreports.com/contacts/inquire-before-buy.php?name=114908 Dallas, TX (PRWEB) September 15, 2014 Stem cells are undifferentiated biological cells that can differentiate into specialized cells and can divide (through mitosis) to produce more stem cells. Stem cell therapy can be applied to treatment...

2014-09-11 23:03:07

Transparency Market Research has published a new report titled "Cell Separation Technologies Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019" to its report store. Albany, New York (PRWEB) September 11, 2014 According to a new market report published by Transparency Market Research "Cell Separation Technologies Market (Technology: Gradient Centrifugation, MACS and FACS; Application: Stem Cell Research, Immunology, Neuroscience and...

2014-09-11 16:28:04

New Facility Poised to Accelerate the Research and Development of Personalized Cellular Cancer Therapies PHILADELPHIA, Sept. 11, 2014 /PRNewswire-USNewswire/ -- The University of Pennsylvania today reached an important milestone in its alliance with Novartis as it unveiled plans for the construction of a first-of-its-kind Center for Advanced Cellular Therapeutics (CACT) on the Penn Medicine campus in Philadelphia. The CACT will become the epicenter for research using Chimeric Antigen...

2014-09-10 20:24:50

LONDON, Sept. 10, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Macular Degeneration (AMD) and Other Retinal Diseases: World Drug Market 2014-2024https://www.reportbuyer.com/product/2006103/Macular-Degeneration-AMD-and-Other-Retinal-Diseases-World-Drug-Market-2014-2024.html Report DetailsAnalysis of revenues and R&D prospects for those eye drugs - you explore potentialsWhat's the future for treating disorders of the retina? Visiongain's updated...

2014-09-10 16:26:29

SAN DIEGO, Sept. 10, 2014 /PRNewswire/ -- ViaCyte, Inc., a privately held regenerative medicine company developing a stem cell-derived islet replacement therapy for the treatment of diabetes, called VC-01, announced today that it has been selected to receive a $16.6 million Accelerated Development Pathway Award from the California Institute for Regenerative Medicine (CIRM). According to CIRM, the Accelerated Development Awards were created to "provide selected applicants who are...

2014-09-10 16:24:07

Media Company Mary Ann Liebert, Inc., Makes Foray from Scientific & Medical Journals to Consumer Arena with Launch of New Non-Fiction Work Inevitable Collision NEW ROCHELLE, New York, Sept. 10, 2014 /PRNewswire/ -- Mary Ann Liebert, Inc., leading publisher of over 80 science, technology, and medical publications, announced today the launch of first time hard cover title Inevitable Collision: The Inspiring Story that Brought Stem Cell Research to Conservative America, in an effort to...

2014-09-08 23:05:50

Okyanos Heart Institute Now Accepting Qualified Heart Disease Candidates for Adult Stem Cell Treatment in New State-of-the-Art Cath Lab Freeport, Grand Bahama (PRWEB) September 08, 2014 Adult stem cell therapy for heart disease has emerged as a new treatment alternative for those living with a poor quality of life as a result of severe coronary artery disease. Okyanos is slated to begin delivering this innovative new treatment in the next several weeks, and is now screening qualified...

2014-09-05 08:24:18

Live Webcast on Wednesday, September 10, at 2:55 p.m. EST GERMANTOWN, Md., Sept. 5, 2014 /PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) announced that President and CEO Richard Garr will present at the 16(th) Annual Rodman & Renshaw Global Investment Conference on Wednesday, September 10, at 2:55 p.m. EST. Garr will provide an overview of the company's NSI-566 cell therapy clinical trials for ALS, which concluded final Phase II treatments in July, and chronic spinal cord...


Word of the Day
malpais
  • The ragged surface of a lava-flow.
'Malpais' translates from Spanish as 'bad land.'